Contineum Therapeutics adopts Executive Severance Plan for named executive officers

Contineum Therapeutics, Inc.

CEO Carmine Stengone designated Tier 1 participant; CSO Lorrain, CFO Slover designated Tier 2 participants.
Non-CIC severance: 12 months base salary + pro-rata bonus; health coverage up to 12 months.
CIC severance: 150% (Tier1) or 100% (Tier2) of salary+bonus; equity acceleration; health to 18/12 mo.
Plan replaces prior severance agreements; participants must sign release and arbitration agreement.
Plan effective May 24; participation agreements executed May 28, 2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.